Drugs / RSV/Flu-01E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05970744 | May → Jun 2023 | respiratory syncytial virus infectious disease | Tatyana Zubkova | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RSV/Flu-01E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05970744 ↗ |
| Modality | Vaccine | “RSV/Flu-01E Vaccine” NCT05970744 ↗ |
| Route | Intranasal | “single intranasal injection” NCT05970744 ↗ |